Direktif Bagi Semua Produk Yang Mengandungi Interferon Alfa dan Interferon Beta dengan Maklumat Keselamatan Berkaitan Risiko Kesan Advers Pulmonary Arterial Hypertension (PAH)
- Posted By MOHD REZUAN BIN AHMAD
- Hits: 12112
National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.